Newcomb M, Swann G, Addington E, Macapagal K, Moskowitz J, Sarno E
Health Psychol. 2025; 44(3):297-309.
PMID: 39992776
PMC: 11879251.
DOI: 10.1037/hea0001448.
Tuan L, Pham L, Khuyen T, Hao B, Hoa N, Vu K
AIDS Behav. 2025; .
PMID: 39928069
DOI: 10.1007/s10461-024-04582-x.
Colver J, Yabes Jr J, Marcus J
AIDS Behav. 2024; 29(2):607-612.
PMID: 39537905
DOI: 10.1007/s10461-024-04543-4.
Unigwe I, Goodin A, Lo-Ciganic W, Cook R, Janelle J, Park H
Open Forum Infect Dis. 2024; 11(10):ofae569.
PMID: 39421701
PMC: 11483608.
DOI: 10.1093/ofid/ofae569.
Velloza J, Liu A, Katz A, van der Straten A, Siegler A, Scott H
AIDS Care. 2024; 36(11):1704-1718.
PMID: 39222964
PMC: 11511627.
DOI: 10.1080/09540121.2024.2397133.
Pre-exposure prophylaxis (PrEP) use trajectories and incidence of HIV and other sexually transmitted infections among PrEP users in Belgium: a cohort analysis of insurance claims data from 2017 to 2019.
Rotsaert A, Smekens T, Jamine D, Di Zinno T, Deblonde J, Lambert M
BMC Public Health. 2024; 24(1):2296.
PMID: 39179990
PMC: 11342504.
DOI: 10.1186/s12889-024-19691-4.
"PrEP a double-edged sword": Integrating implementation science methodology with Photovoice to guide culturally-tailored pre-exposure prophylaxis (PrEP) programs for Latino/a and non-Latino/a men who have sex with men in South Florida.
Johnson A, Self K, Silvey R, Webb G, Kalra N, Fallon S
PLoS One. 2024; 19(8):e0305269.
PMID: 39121065
PMC: 11315311.
DOI: 10.1371/journal.pone.0305269.
Evaluating Dual Process Decision-Making Along the PrEP Consumer Journey: New Insights for Supporting PrEP Use.
Lane B, Nguyen N, Fillmore H, Carnevale C, Sobieszczyk M, Zucker J
AIDS Behav. 2024; 28(9):2850-2862.
PMID: 38801501
PMC: 11390328.
DOI: 10.1007/s10461-024-04357-4.
Restarting pre-exposure prophylaxis (PrEP) for HIV: a systematic review and meta-analysis.
Kiggundu R, Soh Q, Tieosapjaroen W, Fairley C, Tucker J, Tang W
EClinicalMedicine. 2024; 72:102647.
PMID: 38800799
PMC: 11127197.
DOI: 10.1016/j.eclinm.2024.102647.
Perceptions about doxycycline post-exposure prophylaxis (Doxy-PEP) as an STI-prevention strategy among gay and bisexual men (GBM) in the United States: Results from a qualitative study.
Ehsan R, DAngelo A, Westmoreland D, Grov C
Prev Med. 2024; 183:107977.
PMID: 38692309
PMC: 11148872.
DOI: 10.1016/j.ypmed.2024.107977.
Adapting mHealth Interventions (PrEPmate and DOT Diary) to Support PrEP Retention in Care and Adherence Among English and Spanish-Speaking Men Who Have Sex With Men and Transgender Women in the United States: Formative Work and Pilot Randomized Trial.
Liu A, Alleyne C, Doblecki-Lewis S, Koester K, Gonzalez R, Vinson J
JMIR Form Res. 2024; 8:e54073.
PMID: 38536232
PMC: 11007601.
DOI: 10.2196/54073.
Pilot Randomized Controlled Trial of Game Plan for PrEP: A Brief, Web and Text Message Intervention to Help Sexual Minority Men Adhere to PrEP and Reduce Their Alcohol Use.
Wray T, Chan P, Kahler C, Ocean E, Nittas V
AIDS Behav. 2023; 28(4):1356-1369.
PMID: 37971613
PMC: 10947926.
DOI: 10.1007/s10461-023-04223-9.
Strategies to Eliminate Inequity in PrEP Services in the US South and Rural Communities.
Kamitani E, Mizuno Y, Koenig L
J Assoc Nurses AIDS Care. 2023; 35(2):153-160.
PMID: 37963267
PMC: 11090982.
DOI: 10.1097/JNC.0000000000000437.
Online distribution of HIV self-testing kits to promote HIV testing among men who have sex with men discontinuing pre-exposure prophylaxis after demonstration project completion in China: a multicentre open-label randomized controlled trial.
Zhou H, Zhu Y, Gao Y, Chu Z, Chen S, Liu M
Lancet Reg Health West Pac. 2023; 41:100922.
PMID: 37867621
PMC: 10587720.
DOI: 10.1016/j.lanwpc.2023.100922.
Moderating Effect of Pre-Exposure Prophylaxis Use on the Association Between Sexual Risk Behavior and Perceived Risk of HIV Among Brazilian Gay, Bisexual, and Other Men Who Have Sex With Men: Cross-Sectional Study.
Blair K, Torres T, Hoagland B, Bezerra D, Veloso V, Grinsztejn B
JMIR Public Health Surveill. 2023; 9:e45134.
PMID: 37796573
PMC: 10587815.
DOI: 10.2196/45134.
Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
de Vos L, Mudzingwa E, Fynn L, Atujuna M, Mugore M, Gandhi M
J Int AIDS Soc. 2023; 26(9):e26175.
PMID: 37758649
PMC: 10533377.
DOI: 10.1002/jia2.26175.
PrEP Persistence Support and Monitoring in Areas of High HIV Burden in the Midwestern United States.
McNulty M, Kerman J, Devlin S, Pyra M, Rusie L, Curoe K
AIDS Educ Prev. 2023; 35(3):235-246.
PMID: 37410372
PMC: 10328557.
DOI: 10.1521/aeap.2023.35.3.235.
Retrospective audit of a convenience cohort of individuals on HIV pre-exposure prophylaxis in Alberta, Canada.
Candler E, Khan M, Gratrix J, Plitt S, Stadnyk M, Smyczek P
J Assoc Med Microbiol Infect Dis Can. 2023; 7(4):350-363.
PMID: 37397818
PMC: 10312220.
DOI: 10.3138/jammi-2022-0016.
PrEP uptake and persistence amongst HIV-negative women who exchange sex for money or commodities in Kampala, Uganda: A qualitative inquiry assessing the influence of pregnancy.
Joshi S, Namuddu C, Kasujja F, Mirembe M, Homsy J, Seeley J
PLOS Glob Public Health. 2023; 3(6):e0000434.
PMID: 37368866
PMC: 10298783.
DOI: 10.1371/journal.pgph.0000434.
Biomedical and behavioral outcomes of 2GETHER: A randomized controlled trial of a telehealth HIV prevention program for young male couples.
Newcomb M, Swann G, Macapagal K, Sarno E, Whitton S, Mustanski B
J Consult Clin Psychol. 2023; 91(9):505-520.
PMID: 37141032
PMC: 10729837.
DOI: 10.1037/ccp0000823.